Who are we?


Signup for

Online registration

Log in to register
your trial

Search a trial




van CCT (UK)

van CCT (UK)

The usefulness of the questionnaire SIPP-SF in old age to measure the severity of personality problems

- candidate number22523
- NTR NumberNTR5339
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR30-jul-2015
- Secondary IDs15-N-106 METC Atrium - Orbis - Zuyd
- Public TitleThe usefulness of the questionnaire SIPP-SF in old age to measure the severity of personality problems
- Scientific TitleSeverity Indices of Personality Problems Short Form (SIPP-SF) in old age psychiatry: reliability and validity
- hypothesisValidation of the SIPP-SF for elderly
- Healt Condition(s) or Problem(s) studiedPersonality disorder, Older adults
- Inclusion criteriaMen and woman over 65 years of age signed up for psychiatric treatment, with and without a personality disorder
- Exclusion criteriaMMSE equal or below 24, severe psychotic or bipolar problems, estimated IQ lower as 80, substance abuse or addictionproblems
- mec approval receivedyes
- multicenter trialno
- randomisedno
- groupParallel
- TypeSingle arm
- Studytype[default]
- planned startdate 1-sep-2015
- planned closingdate1-nov-2017
- Target number of participants165
- Interventionsasking people to fill in the SIPP-SF
- Primary outcome1) The internal consistency of the five domains of the SIPP-SF;
2) The convergent/divergent validity by comparing scores on the SIPP-SF with scores on the HAP;
3) The discriminant validity by comparing scores on the SIPP-SF between patients without and those with a SCID-II PD diagnosis;
4) Associations between severity of personality pathology as measured by the SIPP-SF and by the SCID II (categorical and dimensional)
- Secondary outcomeThe sensitivity of the SIPP-SF by comparing baseline scores with a follow up measurement 12 months after starting treatment.
- Timepoints1; all primairy outcomes as a baselinescore: scorings at the SIPP-SF, SCID II, HAP en GPS. 2; Secondary outcomes SIPP-SF 12 months after treatment compared to baselinescoring.
- Trial web sitenone
- status[default]
- CONTACT FOR PUBLIC QUERIES B.E. (Barbera) van Reijswoud
- CONTACT for SCIENTIFIC QUERIES B.E. (Barbera) van Reijswoud
- Sponsor/Initiator Mondriaan
- Funding
(Source(s) of Monetary or Material Support)
- Publications
- Brief summaryit will be performed at the Netherlands
- Main changes (audit trail)
- RECORD30-jul-2015 - 25-aug-2015

  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar